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Reducing the concentration of reactive carbonyl species (RCS) in e-cigarette emissions represents a major
goal to control their potentially harmful effects. Here, we adopted a novel strategy of trapping carbonyls
present in e-cigarette emissions by adding polyphenols in e-liquid formulations. Our work showed that
the addition of gallic acid, hydroxytyrosol and epigallocatechin gallate reduced the levels of carbonyls
formed in the aerosols of vaped e-cigarettes, including formaldehyde, methylglyoxal and glyoxal. Liquid
chromatography mass spectrometry analysis highlighted the formation of covalent adducts between
aromatic rings and dicarbonyls in both e-liquids and vaped samples, suggesting that dicarbonyls were
formed in the e-liquids as degradation products of propylene glycol and glycerol before vaping. Short-
term cytotoxic analysis on two lung cellular models showed that dicarbonyl-polyphenol adducts are not
cytotoxic, even though carbonyl trapping did not improve cell viability. Our work sheds lights on the
ability of polyphenols to trap RCS in high carbonyl e-cigarette emissions, suggesting their potential value
in commercial e-liquid formulations.Introduction
The use of e-cigarettes is a major issue in public health.
Proponents of e-cigarettes stress the benets to smokers during
attempts to quit, while opponents fear that e-cigarettes will
attract young people into vaping, thus developing an addiction
to nicotine and possibly transition to combustible tobacco with
time. All agree that e-cigarettes are harmful, but most agree that
their emissions are less harmful than combustible cigarettes as
they contain fewer carcinogens and toxicants, mostly in lower
concentrations.1,2
E-cigarettes have been widely used for about a decade but
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f Chemistry 2020smoking-related symptoms and conditions to becomemanifest,
it is too early to evaluate the long-term clinical effects of vaping
on public health. In the meantime, approaches to predicting
long term effects have been based mainly on extrapolating
short-term clinical trials, chemical studies of emissions, and in
vitro toxicology. Each of these indicates potentially toxic effects
from e-cigarette emissions but generally at much lower levels
when compared to cigarette smoke at equivalent levels of
exposure.3
The WHO estimates that about half of all lifetime smokers
will die of a smoking-related disease and 91% of these deaths
will be directly attributable to cancer, cardiovascular or respi-
ratory disease.4 Reactive carbonyl species (RCS) in the form of
small aldehydes and ketones are biochemical contributors to
each of these diseases. Formaldehyde and acetaldehyde are
among themost potent carcinogens in tobacco smoke,5 acrolein
is implicated in cardiovascular disease, while formaldehyde and
acetaldehyde have respiratory effects.6,7 Some or all of these
carbonyls can also be present in e-cigarette emissions in
quantities that give rise to health concerns;8 it is clear that
reducing their concentrations in emissions could represent
a substantial contribution to harm reduction.
RCS are mainly produced by thermal degradation of glycerol
and propylene glycol present in different ratios in the e-liquid,
serving as carrier solvents. The coil temperature of e-cigarette
devices may induce thermal decomposition of carrier solvents























































































View Article Onlinecarbonyl compounds such as formaldehyde, acetaldehyde,
acrolein, acetone, methylglyoxal and glyoxal, all with estab-
lished toxic effects on human health.9–11
Currently, most strategies for reducing toxicants found in e-
cigarette emissions are based on the design of the product, e.g.
by limiting the opportunity for metal contamination or pre-
venting coils from reaching high temperatures that activate the
degradation of e-liquid.12,13 However, only a few addressed the
chemical nature of the liquid, most notably by using the
propylene glycol/glycerol ratio to limit carbonyl production. A
novel strategy of interrupting the oxidation and fragmentation
pathways of propylene glycol and inhibiting the formation of
RCS can include the use of trapping agents in the form of
polyphenols to minimize the toxic concentrations of RCS in e-
cigarette emissions.
Polyphenols occur naturally in many plants and food prod-
ucts14–16 and are considered to provide health benets when
ingested due to their in vivo antioxidant properties.17 The ability
of phenolic compounds to trap RCS produced in different bio-
logical environments has been demonstrated.18–21 Besides their
chelating and free radical scavenger functions, polyphenols can
act as lipid- and carbohydrate-derived carbonyl scavengers.22
Sang and co-workers23 showed how the A-ring of epigallocatechin
gallate can efficiently react with methylglyoxal to formmono and
di-methylglyoxal adducts. Based on the chemical nature of poly-
phenols, the trapping reactions occur between the electrophilic
carbon of either aldehydes or ketones and the catechol group via
an electrophilic aromatic substitution. The presence of hydroxyl
substituents on the aromatic ring affects both the regioselectivity
and the speed of this reaction, activating and promoting the
substitution in ortho/para positions.24
In this study, we exploited the biological and in vitro RCS
trapping property of gallic acid, hydroxytyrosol and epi-
gallocatechin gallate based on their chemical structures and in
particular to their ability to form adducts with glyoxal and
methylglyoxal.19,23,24 Moreover, we investigated the effects in
a non-biological and ex vivo setting to trap glycerol and
propylene glycol degradation products in the form of carbonyls
and dicarbonyls present in the aerosols of vaped ECs.
Material and methods
Reagents and materials
Glycerol and propylene glycol, 2,4-dinitrophenylhydrazine
(DNPH; 4% in phosphoric acid solution), o-phenylenediamine (o-
PD), 2,4-dinitrophenylhydrazones of aldehyde/ketone–DNPH
stock standard-13 (acetaldehyde–DNPH, acetone–DNPH, acro-
lein–DNPH, benzaldehyde–DNPH, 2-butanone–DNPH, n-butyral-
dehyde–DNPH, crotonaldehyde–DNPH, formaldehyde–DNPH,
hexaldehyde–DNPH, methacrolein–DNPH, propionaldehyde–
DNPH, m-tolualdehyde–DNPH, valeraldehyde–DNPH), methyl-
glyoxal (40% aqueous solution), glyoxal (40% aqueous solution)
and pure polyphenol standard, gallic acid, hydroxytyrosol and
epigallocatechin gallate were obtained from Sigma-Aldrich (St.
Louis, MO). Trizma base (Tris-(hydroxymethyl)-aminomethane
ACS Reagent Grade), solvents for chromatography analysis, such
as acetonitrile, methanol and water, (liquid chromatography-21536 | RSC Adv., 2020, 10, 21535–21544mass spectrometry, LC-MS grade), as well as acetic acid were
purchased from Fisher Scientic (Loughborough, UK). Disodium
hydrogen phosphate and sodium dihydrogen phosphate were
purchased fromMerck (Darmstadt, Germany). Fibrous 4 mmsilica
(“silica wool”) was obtained fromH. Baumbach & Co Ltd, (Suffolk,
UK) and Whatman 47 mm QMA silica lters were obtained from
Sigma-Aldrich.
Sample preparation
The e-liquid formulation was prepared, according to Stephens
et al.,25 by gravimetrically weighing propylene glycol, glycerol
and water in a ratio 70 : 20 : 10 (w/w/w) and used as themodel e-
liquid system. This e-liquid model system was used as a control
sample and compared to e-liquid formulations in which water
was replaced by standard polyphenol solutions. Gallic acid,
hydroxytyrosol and epigallocatechin gallate were prepared at
four concentrations (0.6; 1.25; 2.5 and 5 mM) in Milli-Q water.
Each e-liquid formulation was then vortexed for 1 min, soni-
cated for 3 min to remove bubbles of air and stored at 4 C until
further use. The choice of the selected concentration of phenols
was based on the following criteria: (i) previous data literature,
(ii) cytotoxicity of these phenols on different cell lines, (iii) their
toxicological data such as TDLo, LDLo, LD50 (Lowest Toxic Dose,
Lowest Lethal Dose and Lethal Dose 50) and (iv) the amount of
e-liquid that vapors inhale per day.26–35
Laboratory vaping and aerosol collection
The Subox Mini C device (KangerTech, Shenzhen, China) was
used as a recent generation vaping device in all experiments.
This device incorporates circuitry capable of generating much
higher output voltages to the atomiser than the nominal 3.7 V of
the battery (a regulated box mod in vaping jargon). Another
advantage is that the atomising coil can be easily removed for
visual inspection between vaping runs, without disturbing the
tank containing the e-liquid. The pump, solenoids and atomiser
power supply and controller are part of the Gram Universal
Vaping Machine package (UVM, Gram Health Inc., USA). The
coil received an adequate supply of e-liquid throughout the run
by creating holes in the cotton wrapping around the coil, which
was found to reduce the incidence of wick deposits or burning.25
Aerosol collection and run conditions were carried out accord-
ing to Stephens et al.25 Briey, the aerosol was trapped in a plug
of amorphous silica bres (0.75 g of 4 mm diameter) within
a 10 mL syringe inserted between the e-cigarette mouthpiece
and the pump of the vaping machine. The atomiser was vaped
with a power of 30W to create high temperatures in the 1.5 ohm
coil, which should lead to excess carbonyl production. A thin K-
type thermocouple aligned along the axis of the coil indicated
that temperatures of 166.4 C (s ¼ 4.5, n ¼ 5) were achieved in
the model e-liquid under these conditions. Twenty-ve puffs of
55 mL were drawn over 4 s and repeated every 30 s. Condensate
collection from the silica plug was achieved by centrifuging the
10 mL syringe within a 50 mL centrifuge tube at 4700 rpm, for
5 min. The condensate was immediately sealed and stored at
20 C until required. In order to minimize contamination, 5























































































View Article Onlinesamples and the others for gallic acid, hydroxytyrosol, and
epigallocatechin gallate samples.
HPLC-UV analysis of carbonyl compounds
Carbonyls quantication was carried out according to the
industry-standard method (CORESTA method 74) with some
modications.36 Both e-liquid and condensed vapour were
diluted in acetonitrile (1 : 10), and 50 mL of each sample was
derivatised with 10 mL of 0.02 M DNPH for 25 min to allow the
formation of DNPH-adducts. Samples were stabilized with
Trizma® base solution (acetonitrile/aqueous Trizma 80 : 20) and
analysed using high-performance liquid chromatography (HPLC)
coupled to a UV detector. Chromatographic separations for both
carbonyls and dicarbonyls were achieved using a Raptor ARC-18
(150 4.6 mm, 2.7 mm; Thames Restek, Saunderton, UK) column
set at 40 C. The HPLC-DAD system consisted of a Thermo
Scientic Dionex UltiMate 3000 system (Fisher Scientic),
composed of a degassing device, an ASI-100 automated sample
injector and a PDA-100 photodiode array detector set at 365 nm.
Separation of carbonyls was achieved by injecting 5 mL of deri-
vatised sample using a ow rate of 0.6 mL min1 and an elution
gradient made of ultra-high purity water (solvent A) and aceto-
nitrile mixed with methanol (1 : 14 v/v) (solvent B): 0 min, 70% B;
10min, 75% B; 16min, 90% B; 16.01 min, 100% B; 17min, 100%
B. Limits of quantication for formaldehyde and acetaldehyde
were 0.171 and 0.135 mg mL1, respectively, while corresponding
limits of detection were 0.051 and 0.040 mg mL1, respectively, in
accordance to Stephens et al., 2019.25
HPLC-UV analysis of dicarbonyl compounds
Dicarbonyls were identied and quantied as described by
Hellwig et al.,37 with the following modications: 100 mL of
diluted sample (1 : 10) was mixed with 30 mL of 0.2% o-PD in
9.6 mM EDTA solution and 30 mL of phosphate buffer solution
(0.4 M, pH 7.0) in order to derivatise methylglyoxal and glyoxal
into 2-methylquinoxaline (2-MQx) and quinoxaline (Qx),
respectively. Samples were then incubated at 37 C for 3 h and
analysed. Dicarbonyls separation was achieved on a Raptor
ARC-18 (150  4.6 mm, 2.7 mm; Thames Restek, Saunderton,
UK) column by injecting 20 mL of derivatised sample, which was
eluted with a gradient made of 0.075% acetic acid (solvent A)
and acetonitrile (solvent B): 5 min, 2% B; 22 min, 70% B;
25 min, 70% B at a ow rate of 0.8 mL min1. Compounds were
identied by comparison with pure quinoxalines reference
standards. Calibration curves for dicarbonyls were prepared in
the range 0.06–3.00 mg mL1 in acetonitrile. Limits of quanti-
cation and limits of detection for methylglyoxal and glyoxal
were 0.03 and 0.01 mg mL1, respectively. Results were
expressed as mg mL1.
Liquid chromatography tandem mass spectrometry (HPLC-
ESI-MS/MS) analysis
HPLC-ESI-MS/MS was carried out using a Nexera X2 system
coupled to a LCMS 8040 triple-quadrupole mass spectrometer
(Shimadzu Europa GmbH, Duisburg, Germany) according to
the method described by Navarro and Morales.38 Samples wereThis journal is © The Royal Society of Chemistry 2020separated on a Raptor ARC-18 column (150  4.6 mm, 2.7 mm;
Thames Restek Ltd, Saunderton, UK), at a constant temperature
of 40 C. The column was eluted with a gradient made of 0.5%
acetic acid (solvent A) and methanol (solvent B): 0.1 min, 2% B;
1.5 min, 60% B; 31.5 min, 98% B; 5 min, 98% B, at a ow rate of
0.3 mL min1. A 5 mL aliquot of each sample or standard
compounds was injected for each run and elution proles were
detected using multiple reaction monitoring (MRM). For MS
detection, ionization was carried out in negative mode and MS
settings were optimized through direct ow-infusion of samples
using the method optimisation function of the LabSolutions
soware (Shimadzu Europa GmbH, Duisburg, Germany). The
automatic procedure included the following steps: scanning of
total ion current; optimization and adjustment of precursor
ions; auto-selection of product ions with consequent optimi-
sation of collision energy (CE) with increments of 5 V; accurate
optimisation of Q1 and Q3 voltages. MRM parameters were
checked in the real run. The ion source settings were as follows:
nebulizing gas ow: 3 L min1; desolvation line (DL) tempera-
ture: 250 C; heat block temperature: 400 C; drying gas ow: 15
L min1; collision-induced dissociation (CID) gas: 17 kPa; CE:
5–35 V. Data acquisition and analysis was performed using the
LabSolutions soware.Cell culture and cytotoxicity
The human lung adenocarcinoma cells A549 were maintained
in DMEM (cat. no. 21885108, Gibco™, Fisher Scientic Ltd, UK)
and normal human bronchial epithelial cells BEAS-2B were
maintained in LHC-9 medium (cat. no. 12680013) supple-
mented with 10% FBS and 100 U/100 mg mL1 of Pen/Strep
(Gibco™, Fisher Scientic Ltd, UK), under a 5% carbon
dioxide atmosphere, at 37 C. Cell viability assay was performed
as previously described39,40 but using CellTiter-glo3D (cat. no.
G9682, Promega, UK) following manufacturers' instructions.
Briey, A549 and BEAS-2B cells were seeded at a density of 1 
104 in an opaque 96 well plate, and allowed to formmonolayers,
overnight. Then, media containing varying concentrations
(nal concentration ranging from 10.0–0.001 mM) of antioxi-
dants with or without condensed aerosol were added, and
incubated for 24 and 48 h. Control cells received water or
antioxidants dissolved in water. Aer treatment, equal volume
of media and CellTiter-glo3D were added, placed on a shaker for
2 min, and then equilibrated at room temperature for 10 min to
stabilize the luminescence signal. Further, luminescence was
measured using a Luminometer (Anthos Lucy1); the corre-
sponding signal, which is directly proportional to the ATP level
in viable cells, was used to calculate cell viability relative to
control cells (water). The results were obtained in triplicates and
expressed as mean  SEM of viable cells relative to the control.Statistical analysis
All samples were analysed in three independent replicates and
results are presented as mean values  standard deviation of
analytical and technical replicates. Data were analysed by























































































View Article OnlineSignicant differences between samples with a condence
interval of 95% were determined using Tukey's range test.Fig. 1 Heat-map showing the concentration of carbonyls and dicar-
bonyls in the aerosols of vaped e-cigarettes after addition of phenolic
compounds in the e-liquid formulations. The addition of polyphenols
reduced carbonyl and dicarbonyl concentration in the corresponding
aerosols. Data were subjected to one-way ANOVA and significant
differences (P# 0.05) between means were determined using Tukey's
test. Lowercase letters denote differences between treatments for
each reactive carbonyl species. Each block is the mean value of three
replicates  SE, n ¼ 3. C, control (model e-liquid system); EGCG,
epigallocatechin gallate; nd, not detected; ns, not significant. Other
carbonyls were area summed from known and unknown peaks as
previously reported by Stephens et al., 2019.25 Boxes without letters,
below limit of quantification.Results and discussion
Reducing reactive carbonyl species
Several studies have demonstrated the capacity of polyphenols
to trap RCS23,24,41–43 in solid model systems or in closed reactors.
Three phenolic compounds (gallic acid, hydroxytyrosol, and
epigallocatechin gallate) were used to reduce the levels of glyc-
erol and propylene glycol degradation products present in the
aerosols of vaped laboratory-formulated e-cigarettes, such as
carbonyls and dicarbonyls. The addition of polyphenols in the
e-liquid formulations reduced the concentration of RCS in the
aerosol condensate, except for: (i) glyoxal in the experiment with
gallic acid; (ii) acetaldehyde and glyoxal in the experiment with
hydroxytyrosol; (iii) acetaldehyde and glyoxal in the experiment
with epigallocatechin gallate. Moreover, the addition of 0.6 mM
epigallocatechin gallate in the e-liquid formulation did not alter
the concentration of carbonyls in the aerosol condensate,
except for methylglyoxal (MGO) that was reduced by 14%
(Fig. 1). In the gallic acid e-cigarette model system (0.6; 1.25; 2.5
and 5 mM), the concentration of formaldehyde, acetaldehyde,
methylglyoxal, and other carbonyls decreased up to 99.6%,
100%, 82.2, and 76%, respectively, compared with the control
model system. A similar trend was observed for hydroxytyrosol
(formaldehyde, methylglyoxal and other carbonyls) and epi-
gallocatechin gallate (formaldehyde, methylglyoxal, and other
carbonyls) model systems. The concentrations of carbonyl
compounds were in the same order of magnitude as those re-
ported by Uchiyama et al.,44 which ranged from 0.3 to 61 mg
mL1, depending on the carbonyl compound and the e-cigarette
brand. Formaldehyde and acetaldehyde were the main
carbonyls identied and quantied in the condensed aerosols
as DNPH derivatives. Specically, we used DNPH because it is
highly selective for carbonyl compounds, even in the presence
of thiol groups and other nucleophiles in the sample, other
DNPH azo-derivatives can be formed as well.45 In contrast to
commercial e-liquids, which are rich in esters, alcohols, ketones
and aldehydes with no sulphur present in their molecular
structures,46 we used a laboratory-prepared model e-liquid
system with no avours or nicotine added and vaped at high
power (30 W). This strategy maximised the generation of
carbonyls and minimised the impact of added ingredients on
the estimation of the unknown peaks, excluding them as
putative contributors to the total amount of carbonyls formed.Trapping of carbonyls and formation of adducts
Fig. 2 shows the reduction of phenolic compounds in the e-
liquid and aerosol condensate samples. The results indicate
that the concentration of all polyphenols decreased aer vap-
ing, regardless of their initial concentration in the e-liquid
(Fig. 2). The decrease of polyphenols ranged from 60–98%,
implying their potential involvement in dicarbonyl trapping, as
well as their oxidation and further reactions as condensation,
polymerization or cleavage.47 These quantitative measurements21538 | RSC Adv., 2020, 10, 21535–21544took into account the compound recovery factors associated
with e-liquid mixture volatilization (between 50 and 70 C), and
adsorption/release of phenols from silica plugs, as already
determined by our group.25
Along with the reduction of dicarbonyls and polyphenols, we
further investigated the formation of adducts by using tandem
mass spectrometry. We focused on the formation of adducts
between polyphenols and glyoxal or methylglyoxal or polyphenols
derivatives as 3,4-dihydroxyphenylacetaldehyde (DOPAL) and
pyrogallol and glyoxal or methylglyoxal, because of the non-
volatile nature of the latter compounds. Based on electrophilic
aromatic substitution proposed in the literature,23,42 we searchedThis journal is © The Royal Society of Chemistry 2020
























































































View Article Onlinefor putative chemical structures of adducts as outlined in Fig. 3.
According to the experimental conditions in the condensed e-
liquid, not all the compounds envisaged were detected in mass
spectrometry analyses as a consequence of low concentrations or
as a result of intramolecular rearrangements leading to molecular
structures different from those hypothesized. Working on
precursor ions detection, we obtained structural information on
molecular ion starting with selected ion monitoring mode (SIM).
Table 1 shows the main putative adducts identied in this study,
along with corresponding retention times, precursor and product
ions. For the experiment with gallic acid, a mechanism of decar-
boxylation with the formation of pyrogallol has been hypothesized
for its high scavenging activity of dicarbonyls.24 Fig. 4 illustrates
the abundance of each adduct in the model system investigated
upon MRM experiments.
For gallic acid and hydroxytyrosol, we identied two, and one
adduct, respectively. In particular, we ascertained the occur-
rence of mono- and di-methylglyoxal adducts of the hydrox-
ybenzoic derivative. In the case of mono-methylglyoxal adducts
deriving from the reaction of gallic acid with methylglyoxal, we
observed a major peak with a molecular ion atm/z 241 [MH]
(Fig. 4), which generated a fragment ion at m/z 209 [M  H]
compatible with parental molecular structure, resulting from
the loss of the oxygen atoms present at two hydroxyl groups.
Whereas the mono-methylglyoxal adduct with gallic acid wasThis journal is © The Royal Society of Chemistry 2020evident in both liquid and vaped samples, the di-methylglyoxal
adduct was detected only in vaped samples (Fig. 4). The prod-
ucts deriving from the reaction of glyoxal with gallic acid were
not observed. These ndings may be associated with higher
reactivity of methylglyoxal toward polyphenols with respect to
glyoxal, as already described by previous studies.48
Regarding hydroxytyrosol, we did not identify its mono- and
di-molecular adducts of glyoxal and methylglyoxal, but the
mono-glyoxal adduct of a corresponding degradation product,
namely 3,4-dihydroxyphenylacetaldehyde (DOPAL) (Table 1).
Navarro and Morales29 investigated the mechanism of methyl-
glyoxal trapping by hydroxytyrosol monitoring the degradation
of HT and the formation of related compounds of degradation.
They found that, aer 168 h at 37 C in physiological conditions
mimicking biological uids, the amount of HT decreased
(>98.2%) linearly over the time of the incubation. Using HPLC-
ESI-QTOF-MS technique, authors identied as HT degradation
products two main molecules: DOPAC and DOPAL (3,4-
dihydroxyphenyl-acetic acid and 3,4-dihydroxyphenyl-
acetaldehyde, respectively). They assume that HT oxidizes to
DOPAL and later to DOPAC, which undergo through electro-
philic aromatic substitution with methylglyoxal. Since no
adducts of HT with methylglyoxal and glyoxal were detected, we
envisaged a preference of the hydroxytyrosol degradation
product for glyoxal, presumably as a result of the stericRSC Adv., 2020, 10, 21535–21544 | 21539
Fig. 3 Molecular structures and their exact masses of hypothesized adducts. Abbreviations used: HT, hydroxytyrosol, EGCG, epigallocatechin























































































View Article Onlinehindrance of the methyl group of methylglyoxal and different
reaction kinetics of these dicarbonyl compounds. The different
reaction conditions (temperature, time and solvent) could21540 | RSC Adv., 2020, 10, 21535–21544explain why we only found DOPAL as degradation product, but
further investigations are needed to better understand the
mechanism of reaction.This journal is © The Royal Society of Chemistry 2020
Table 1 Mass spectrometric data of the adducts hypothesized and identified in condensed e-liquid samples in which the water fraction was
replaced by a solution containing gallic acid, hydroxytyrosol or epigallocatechin gallate, at different concentrations. GO, glyoxal; MGO,
methylglyoxal; Pyr, pyrogallol; DOPAL, 3,4-dihydroxyphenylacetaldehyde; n.d., not detected
Adducts RT (min) [M  H] (m/z) Fragment ions (m/z) Collision energy (V)
Gallic acid (GA)
GA + GO n.d. n.d. n.d. —
GA + 2GO n.d. n.d. n.d. —
GA + MGO 15.11 241.20 209.25 15
GA + 2MGO 6.67 313.10 75.05, 91.05 43, 15
GA + GO + MGO n.d. n.d. n.d. —
Pyr + GO n.d. n.d. n.d. —
Pyr + 2GO n.d. n.d. n.d. —
Pyr + MGO n.d. n.d. n.d. —
Pyr +2MGO n.d. n.d. n.d. —
Pyr + GO + MGO n.d. n.d. n.d. —
Hydroxytyrosol (HT)
DOPAL + GO 15.17 209.10 153.15, 79.00 14, 22
DOPAL + MGO n.d. n.d. n.d. —
HT + GO n.d. n.d. n.d. —
HT + MGO n.d. n.d. n.d. —
Epigallocathechin gallate (EGCG)
EGCG + GO n.d. n.d. n.d. —
EGCG + 2GO n.d. n.d. n.d. —
EGCG + MGO n.d. n.d. n.d. —
EGCG + 2MGO 30.66 567.10 299.15 15
31.16 567.10 299.15 15
EGCG + GO + MGO n.d. n.d. n.d. —
Fig. 4 The formation of adducts between phenolic compounds and dicarbonyls in e-liquid (SEL) and aerosol condensate samples after addition
of phenolic compounds in the e-liquid formulations. DOPAL, 3,4-dihydrophenyl-acetaldehyde; EGCG, epigallocatechin gallate; GA, gallic acid;
GO, glyoxal; MGO, methylglyoxal.














































































































































































View Article OnlineRegarding epigallocatechin gallate derivatives, we identied
a putative precursor ion at m/z [M  H] 567 that suggested
a preliminary adduction with two methylglyoxal molecules
(C28H26C15, exact mass 602.13), followed by oxidation into
quinone and nally an intramolecular aldol condensation
yielding the formation of two additional rings. The nal dehy-
dration of two hydroxyl groups introduced two molecular
unsaturation. In the presence of reducing agents in combina-
tion with a high concentration of glycol, we postulated
a reduction of the benzoate ring into alcohol upon complexa-
tion of cation, according to the procedure detailed by Santa-
niello and co-workers that investigated the reduction of several
esters into alcohol by means of sodium borohydride and poly-
ethylene glycols.49 The mechanism reported in Fig. 5 is puta-
tively and essentially based on Cannizzaro reaction50 with
a preliminary oxidation of the hydroxyl group into carbonyl and
the consequent reaction with methyl group, nally the removal
of the two water molecules yielded the structure depicted in
Fig. 5 with a [M  H] signal at m/z 567 (C28H24C13, exact mass
568.12). This precursor ion generated a main fragment at m/z
299 [M 268H], which is fully compatible with the chemical
structure hypothesized. In this respect, the high temperature
reached during vaping played a crucial role in propylene glycol
and glycerol transformation, as different adducts were identi-
ed in nal reaction products with respect to those ascertained
in previous studies.23 Thus, it is possible that under the exper-
imental conditions, which involves a rapid increase in
temperature, the di-methylglyoxal adduct of epigallocatechin
gallate already described by Sang et al.23 for the reaction per-
formed about 37 C further decomposes to yield different
molecular species with a chemical structure and an exact mass
similar to the one postulated in Fig. 5. An alternative mecha-
nism to the one reported in Fig. 5 is based on the condensation
of carbonyl group with a nal formation of two pyran rings,
which also yielded a nal product with a [M  H] signal at m/z
567. Further studies based on the use of isotopically-labelled
reagents and additional spectroscopic/spectrometric tech-
niques, as well as UV characterization are necessary to nally
address this issue.
Relevant components of our model e-liquids (propylene
glycol, glycerol and water) degraded prior to vaping, and the
addition of polyphenols led to the formation of adducts with
dicarbonyls. The same adducts were also identied in the vaped
condensate. This suggests that dicarbonyls have formed in theFig. 5 Putative pathway leading to the formation of the epigallocatechin
plus two methylglyoxal residues.
21542 | RSC Adv., 2020, 10, 21535–21544e-liquids prior to vaping, presumably as degradation products
of the major ingredients. Bekki et al.51 attributed the formation
of carbonyls and dicarbonyls in e-cigarette aerosols to the
oxidation of the e-liquid, when it becomes in contact with the
heated atomiser coil in the presence of atmospheric oxygen. The
present study suggests that the compounds observed by Ooi
et al.52 are formed in the e-liquid of our model system prior to
vaping, in part or in the whole. The difficulty in quantifying the
concentration of these adducts prevented a fuller assessment of
the role of each phenol compounds in reducing carbonyl
formation. Nevertheless, it seems that the addition of appro-
priate polyphenols to the e-liquid potentially limited the
production of toxic carbonyls, whether prior to vaping, during
vaping-related heating, and/or in the aerosol. Along with glyc-
erol and propylene glycol, other additives deserve further
attention: Wu and O'Shea showed that the vaping of the viscous
lipid oil vitamin E acetate has the potential to produce phenyl
acetate and the toxic ketene, which may be a contributing factor
to pulmonary injuries associated with using e-cigarette/vaping
products.53 In this respect, pyrolysis experiments and study of
degradation of polyphenols can open new scenario on the
formation chemical routes behind the trapping of carbonyls
compounds.
Regarding the nature of the toxic molecules formed in e-
liquids, the degradation of glycerol was already suggested to
play a central role in the formation of intermediates as
hydroxypropanal, acetol and 2,3-hydroxypropanal, with the
latter compound being a key precursor in the formation of
methylglyoxal and 2,3-butanedione.54 In particular, methyl-
glyoxal is formed in large amounts during catalytic conversion
of glycerol via 2,3-hydroxypropanal; conversely, acetol generates
only trace amounts of reactive a-dicarbonyls.55 The nature of the
compounds here ascertained provided information on the most
reactive dicarbonyl molecules present in e-liquids.Cytotoxicity of liquid and aerosol samples on two lung cell
lines
The short-term cytotoxic effects of e-cigarette aerosols on two
lung cellular models, namely alveolar (A549) and bronchial
(BEAS-2B) cell lines, was also investigated (Fig. 6). A series of
dilutions of the e-cigarette aerosols were used to examine their
cytotoxicity relative to vehicle control. Moreover, we examined
whether the RCS-trapping phenolics, gallic acid, hydroxytyrosolgallate adduct (m/z [M H] 567) as degradation product of the EGCG
This journal is © The Royal Society of Chemistry 2020
Fig. 6 Short-term cytotoxic effect of e-cigarette aerosols on two lung cellular models, alveolar (A549) and bronchial (BEAS-2B) cell lines. Data
were subjected to one-way ANOVA and significant differences (P# 0.05) betweenmeans were determined using Tukey's test. Asterisks indicate
differences between treatments of the same dilution in relation to the control water. Bars are the mean value of three replicates  SE, n ¼ 3. CC,























































































View Article Onlineand epigallocatechin gallate, can attenuate the cytotoxicity of e-
cigarettes. In addition to condensed aerosols, we also tested the
cytotoxicity of the polyphenols that were previously diluted in
water. Regardless of cell line and incubation period, the viability
of both alveolar A549 and bronchial BEAS-2B cells was overall
similar between treated and control samples. We apparently
observed some discernible and slight increase in cell viability for
both cell lines when the e-cigarette liquid was combined with the
polyphenols, especially at 10, 1, and 0.01 mM concentrations aer
24 h. This increased viability was slightly higher for the alveolar
A549 cells than for the BEAS-2B cells, but overall, the two cell
lines responded similarly to the treatments. These ndings
suggest that the formation of adducts does not have a negative
impact on the cell viability within a 24–48 h period of treatment.
In conclusion, our work has established the ability of poly-
phenols to trap RCS in laboratory-formulated liquids vaped at
high power (30 W), suggesting their potential value in commer-
cial e-liquid formulations for reducing the levels of harmful
carbonyls to which vapors are exposed. Overall, this study iden-
ties a potential public health benet in the apparently inhibit-
ing effect of polyphenols on carbonyl production in e-cigarette
liquids and emissions. The magnitude of this inhibiting effect,
particularly its application to real-world vaping using other
formulations and vaped at other power settings, and its potential
impact on vaping populations require further dedicated investi-
gations. This study also provides original information on the
potential toxic activity of the resulting dicarbonyl-polyphenol
adducts, revealing that the newly generated compounds in e-cig
aerosols have no effect on cell viability. However, further
studies are required in order to establish a cause–effects rela-
tionship between polyphenols and RCS.This journal is © The Royal Society of Chemistry 2020Funding source
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43 M. Meśıas, M. Navarro, V. Gökmen and F. J. Morales, J. Sci.
Food Agric., 2013, 93, 2037–2044.
44 S. Uchiyama, K. Ohta, Y. Inaba and N. Kunugita, Anal. Sci.,
2013, 29, 1219–1222.
45 I. Dalle-Donne, M. Carini, M. Orioli, G. Vistoli, L. Regazzoni,
G. Colombo, R. Rossi, A. Milzani and G. Aldini, Free Radicals
Biol. Med., 2009, 46, 1411–1419.
46 P. A. Tierney, C. D. Karpinski, J. E. Brown, W. Luo and
J. F. Pankow, Tob. Control, 2016, 25, e10–e15, DOI: 10.1136/
tobaccocontrol-2014-052175.
47 S. Bittner, Amino Acids, 2006, 30, 205–224.
48 X. Li, T. Zheng, S. Sang and L. Lv, J. Agric. Food Chem., 2014,
62, 12152–12158.
49 E. Santaniello, P. Ferraboschi and P. Sozzani, J. Org. Chem.,
1981, 46, 4584–4585.
50 C. G. Swain, A. L. Powell, W. A. Sheppard and C. R. Morgan, J.
Am. Chem. Soc., 1979, 101, 3576–3583.
51 K. Bekki, S. Uchiyama, K. Ohta, Y. Inaba, H. Nakagome and
N. Kunugita, Int. J. Environ. Res. Public Health, 2014, 11,
11192–11200.
52 B. G. Ooi, D. Dutta, K. Kazipeta and N. S. Chong, ACS Omega,
2019, 4, 13338–13348.
53 D. Wu and D. F. O'Shea, Proc. Natl. Acad. Sci. U. S. A., 2020,
117, 6349–6355, DOI: 10.1073/pnas.1920925117.
54 I. Martinuzzi, Y. Azizi, J. Devaux, S. Tretjak, O. Zahraa and
J. Leclerc, Chem. Eng. Sci., 2014, 116, 118–127.
55 A. Corma, G. W. Huber, L. Sauvanaud and P. O'Connor, J.
Catal., 2008, 257, 163–171.This journal is © The Royal Society of Chemistry 2020
